Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis

被引：0
|
作者：
Shamar Young
Tina Sanghvi
Nathan Rubin
Damian Hall
Luke Roller
Yassine Charaf
Jafar Golzarian
机构：
[1] University of Minnesota,Department of Radiology, Division of Interventional Radiology
[2] Minneapolis VA Health Care System,VA Department of Radiology
来源：
CardioVascular and Interventional Radiology | 2020年 / 43卷
关键词：
Nonalcoholic fatty liver disease; Chemoembolization; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 75
页数：10
相关论文
共 50 条
  • [41] Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study
    Guo, Peng
    Pi, Xingtao
    Gao, Feng
    Li, Qiang
    Li, Duqiang
    Feng, Wendong
    Cao, Wendong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study
    Lei Wang
    Nanping Lin
    Kongying Lin
    Chunhong Xiao
    Ren Wang
    Jingbo Chen
    Weiping Zhou
    Jingfeng Liu
    Journal of Gastrointestinal Surgery, 2021, 25 : 1172 - 1183
  • [43] Comparison of Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma in Patients With Hepatitis C and Other Causes
    Dines, M.
    Ray, C.
    Durham, J.
    Gupta, R.
    Rochon, P.
    Babson, K.
    Condo, K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
  • [44] Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
    Zhu, Di
    Ma, Kun
    Yang, Wei
    Zhou, Hai-Feng
    Shi, Qi
    Ren, Jian-Wu
    Xie, Yu-Guan
    Liu, Sheng
    Shi, Hai-Bin
    Zhou, Wei-Zhong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study
    Chong Zhong
    Yong-Fa Zhang
    Jun-Hai Huang
    Cheng-Ming Xiong
    Zi-Yu Wang
    Qing-Lian Chen
    Rong-Ping Guo
    BMC Cancer, 18
  • [46] Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study
    Zhong, Chong
    Zhang, Yong-Fa
    Huang, Jun-Hai
    Xiong, Cheng-Ming
    Wang, Zi-Yu
    Chen, Qing-Lian
    Guo, Rong-Ping
    BMC CANCER, 2018, 18
  • [47] A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
    Zeng, Hao
    Su, Ke
    Chen, Xiaojing
    Li, Xueting
    Wen, Lianbin
    Song, Yanqiong
    Chen, Lan
    Li, Han
    Guo, Lu
    Han, Yunwei
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
    Hao Zeng
    Ke Su
    Xiaojing Chen
    Xueting Li
    Lianbin Wen
    Yanqiong Song
    Lan Chen
    Han Li
    Lu Guo
    Yunwei Han
    Scientific Reports, 13
  • [49] Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
    Chien, Shih-Chieh
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Liu, Yi-Shan
    Cheng, Hsiu-Chi
    Chuang, Chiao-Hsiung
    Chang, Ting-Tsung
    Chiu, Hong-Chi
    Lin, Yih-Jyh
    Chiu, Yen-Cheng
    LIVER CANCER, 2019, 8 (03) : 186 - 202
  • [50] Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
    Huang, Yonghui
    Chen, Bin
    Liu, Ni
    Li, Nan
    Dao, Haitao
    Chen, Wei
    Yang, Jianyong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (06) : 498 - 508
12345